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Connexin36 knockoutNeurons in the enteric nervous system utilize numerous neurotransmitters to orchestrate rhythmic
gut smooth muscle contractions. We examined whether electrical synapses formed by gap junctions
containing connexin36 also contribute to communication between enteric neurons in mouse colon.
Spontaneous contractility properties and responses to electrical ﬁeld stimulation and cholinergic
agonist were altered in gut from connexin36 knockout vs. wild-type mice. Immunoﬂuorescence
revealed punctate labelling of connexin36 that was localized at appositions between somata of
enteric neurons immunopositive for the enzyme nitric oxide synthase. There is indication for a pos-
sible functional role of gap junctions between inhibitory nitrergic enteric neurons.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The enteric nervous system (ENS) plays a major role in the reg-
ulation of gastrointestinal homeostasis. Enteric neurons in both the
myenteric plexus and submucosal plexus contain a plethora of
classical and peptide neurotransmitters, with often several present
in the same neuron, that have been used to classify subpopulations
of neurons according to their transmitter content, anatomical orga-
nization and contributions to microcircuitry governing gut con-
tractile activity [1,2]. Among the multiple transmitters in
individual excitatory or inhibitory enteric neurons, some have pri-
mary roles in neural control of gut smooth muscle contraction,relaxation, sensory feedback and reﬂex activity [3]. Contraction is
mainly driven by neurons that release tachykinins and acetylcho-
line, while relaxation results form activation of non-adrenergic
and non-cholinergic neurons, including those that release vasoac-
tive intestinal polypeptide, ATP and nitric oxide (NO). In addition,
gap junctional intercellular communication (GJIC) channels con-
nect smooth muscle cells and interstitial cells of Cajal in various
conﬁgurations, and thereby spread pacemaker and contractile sig-
nals regulated by enteric neurons [4–6]. Among the twenty or so
connexin proteins (designated Cx followed by MW) that form
gap junctions, creating pores that allow intercellular passage of
ions and small molecules between cells [7], those expressed in
the deep muscular and submuscular plexuses of the intestinal sys-
tem include Cx40, 43 and 45 [8–12]. Studies involving the use of
gap junction blockers and mice with ablation of Cx43 have indi-
cated a functional contribution of GJIC provided by these connexins
to patterns of intestinal smooth muscle activity [13–15].
Recently, Frinchi et al. [16] reported expression of connexin36
(Cx36) in an as yet undetermined cell type in mouse ileum and co-
lon, and noted ‘‘that it has been known for a long time that the
myenteric plexus can mediate neural activity in the gastrointesti-
nal musculature through interneuronal communication by gap
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gut. To our knowledge and contrary to their statement, gap junc-
tions between neurons in the ENS have not been described. Never-
theless, based on studies of Cx36 in the CNS, their observation
raised the possibility of a contribution of this connexin to GJIC be-
tween enteric neurons. In the CNS, it is well established that Cx36
is widely expressed in a variety of neuron types, often though not
always in inhibitory gamma-aminobutyric acid (GABAergic) neu-
rons [17–19], and forms gap junctions that are the structural sub-
strate of electrical synapses [20]. Electrical synapses in the CNS
confer synchronous neuronal activity by linking electrical oscilla-
tions among ensembles of gap junctionally coupled neurons, and
thus temporally correlate ﬁring patterns in otherwise disparate
networks [19]. It is widely considered that synchronous neuronal
activity in the CNS underlies a broad range of information process-
ing. These points, supported by studies of Cx36 knockout (ko) mice
[17,19], indicate indispensable roles of electrical synapses in neural
network properties in the CNS.
The formation of electrical synapses in the ENS could be equally
important in orchestrating the activity of enteric neurons in their
control of complex patterns of gut contractility. In the present
study, we conducted immunoﬂuorescence analyses of Cx36 in
combination with neuronal markers, focusing speciﬁcally on inhib-
itory neurons that express neuronal nitric oxide synthase (nNOS).
In addition, we examined EGFP reporter expression in the ENS of
transgenic mice in which this reporter is driven by the Cx36 pro-
moter. Further, we used in vitro organ bath chambers to investigate
contractility parameters of gut from wild-type vs. Cx36 ko mice.
2. Materials and methods
2.1. Animals
The present studies involved the use of three Sprague-Dawley
adult rats, and a total of eighteen mice of the C57BL/6-129SvEv
strain with a targeted disruption of the Cx36 gene (Cx36(/))
and their Cx36(+/+) wild-type (WT) littermates, and four mice in
which Cx36 expression is normal and bacterial artiﬁcial chromo-
some provides EGFP expression driven by the Cx36 promoter, des-
ignated EGFP-Cx36 mice. Colonies of the C57BL/6-129SvEv wild-
type and Cx36 ko mice [21] were established at the University of
Manitoba through generous provision of breeding pairs of these
mice from Dr. David Paul (Harvard). The EGFP-Cx36 mice were ta-
ken from a colony of these mice maintained at the University of
Manitoba and originally obtained from UC Davis Mutant Mouse
Regional Resource Center (designated Tg(Gjd2-EGFP)16Gsat/
Mmcd Cx36 EGFP mice; strain FVB/N-Crl:CD1(ICR) hybrid; Davis,
CA, USA (see also http://www.gensat.org/index.html). The mice
were matched for age, body weight (22–25 g), and allowed ad libi-
tum access to standard laboratory chow and water. All mice were
maintained in a double barrier unit in a room that had controlled
temperature (21 ± 2 C), humidity (65–75%), and light cycle (12 h
light/12 h dark). All animals were used in accordance to protocols
approved by the Central Animal Care Committee of the University
of Manitoba (10-073 and 10-431).
2.2. In vitro analyses of smooth muscle contraction
Mice were euthanized by cervical dislocation and segments of
distal colon were removed, submerged in ice-cold oxygenated
Krebs solution (120 mM NaCl, 1.4 mM NaH2PO4, 15 mM NaHCO3,
5.8 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2 and 11 mM glucose).
Preparations were gently ﬂushed to remove luminal contents. A to-
tal of 10 mice were taken to generate twenty colonic strips. Seg-
ments of colon, 1 cm in length, were ligated at each end with silkthread and suspended longitudinally in each of up to eight cham-
bers of 15 ml isolated organ baths (Panlab Harvard Apparatus,
Holliston, Massachusetts, USA), containing Krebs solution main-
tained at 37 C and aerated with 95% O2/5% CO2. These prepara-
tions were positioned between a pair of parallel platinum
electrodes, separated by 1.4 cm, and attached to an isometric force
transducer (MLT0201 AD Instruments, Dunedin, New Zealand).
Spontaneous smooth muscle activity (SMA) and responses to elec-
trical ﬁeld stimulation (EFS) were measured in isometric condi-
tions. The mechanical activity of the muscle was measured using
a transducer ampliﬁer relayed to a bioelectric ampliﬁer (ML228,
AD Instrument) equipped to record muscle contractions via a data
acquisition system (PowerLab16/30, ADinstrument, CO, USA). At
the beginning of each experiment, muscle strips were stretched
to their optimal resting tone. This was achieved by step-wise in-
creases in tension until the contractile responses between two
EFS were maximum and reached stable amplitude. The target
stretching set point was 9 millinewton (mN), and a 15 min equili-
bration time was incorporated between every stretch. Typically,
muscle strips were stretched to 180 ± 15% of their initial length.
SMA was characterized 15 minutes after the last EFS followed by
a bath solution change, and included measurements of tone as well
as amplitude and frequency of spontaneous contractions over
three one-minute periods. To examine muscle contractility re-
sponse to EFS, colonic preparations were subjected to EFS with
the following parameters; monophasic train with train duration
of 10 s, pulse rate of 16 pulses per second, pulse duration of
0.5 ms, pulse delay of zero seconds, and a voltage of 24 volts (Grass
S88X, Grass Technologies, Natus Neurology, Middleton, WI, USA).
EFS parameters were chosen by modifying the frequency and volt-
age to obtain maximal relaxation and C-off for a 9 mN tension. Dif-
ferent values of voltage (5, 10, 15 and 24 V), and frequencies (5, 10,
16 Hz), and the optimal combination was chosen. Contractility re-
sponse values are presented as the average of three repetitions of
the EFS-generated contractility response. At the end of the applied
EFS, and after two bath solution changes (10 min interval), contrac-
tile responses to cholinergic stimulation were assessed by expo-
sure to three doses of carbachol. Gut segments were exposed to
non-cumulative ﬁnal bath concentrations of 1, 10 and 100 lM car-
bachol by addition of microliter aliquots to 15 ml tissue baths.
After the maximal tone response to each dose was obtained
(5 min), tissues were rinsed twice and equilibrated in fresh Krebs
solution for 15 min before addition of the next agonist dose. In-
creased tone was calculated from the mean basal tone and maxi-
mal point of response.
The force generated by spontaneous SMA, responses to EFS and
dose-response to carbachol are expressed in mN and normalized
for cross-sectional area as determined by the following equation:
cross-sectional area (mm2) = tissue wet weight (mg)/[tissue length
(mm)  density (mg/mm3)], where density of smooth muscle was
deﬁned to be 1.05 mg/mm3 [22]. Results are expressed as the
mean ± S.E.M., and differences between groups were evaluated
using a Student’s t-test for unpaired data. Difference were consid-
ered signiﬁcant at P < 0.05.
2.3. Immunoﬂuorescence procedures
Tissues taken for immunoﬂuorescence labelling were prepared
by transcardiac perfusion with a series of solutions. Adult mice
and rats were euthanized with an overdose of equithesin (3 ml/
kg), placed on a bed of ice, and perfused ﬁrst with cold (4 C)
pre-ﬁxative (20 ml per 100 g body weight) consisting of 50 mM so-
dium phosphate buffer, pH 7.4, 0.1% sodium nitrite, 0.9% NaCl and
1 unit/ml of heparin. For experiments involving immunohisto-
chemical detection of Cx36, animals were then perfused with ﬁxa-
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7.4, 0.2% picric acid and either 1% or 2% formaldehyde diluted from
a 20% stock solution (Electron Microscopy Sciences, Hatﬁeld, PA,
USA). The perfusate volumes were 50–100 ml per 100 g body
weight. For experiments involving immunohistochemical detec-
tion of EGFP, mice were perfused with ﬁxative solution containing
cold 0.16 M sodium phosphate buffer, pH 7.4, 0.2% picric acid and
4% formaldehyde. The ﬁxative perfusion was followed by perfusion
of animals with a solution containing 10% sucrose and 25 mM so-
dium phosphate buffer, pH 7.4, to wash out excess ﬁxative. Duode-
num, jejunum, ileum and colon were removed and stored at 4 C
for 24–48 h in cryoprotectant containing 25 mM sodium phos-
phate buffer, pH 7.4, 10% sucrose, 0.04% sodium azide. Transverse
or horizontal sections of gut were cut at a thickness of 10–15 lm
using a cryostat and collected on gelatinized glass slides. Slide-
mounted sections were stored at 35 C until use.
Immunoﬂuorescence labelling was conducted with primary
antibodies used in various combinations. Anti-Cx36 antibodies
were obtained from Life Technologies Corporation (Grand Island,
NY, USA) (formerly Invitrogen/Zymed Laboratories), and those
used included two rabbit polyclonal antibodies (Cat. No. 36-4600
and Cat. No. 51-6300) and one mouse monoclonal antibody (Cat.
No. 39-4200). These anti-Cx36 antibodies were incubated with tis-
sue sections at a concentration of 1–2 lg/ml. Monoclonal anti-
EGFP developed in rabbit or polyclonal anti-EGFP developed in
chicken were obtained from Life Technologies Corporation and
Aves Labs Inc. (Tigard, Oregon, USA), respectively, and used at a
concentration of 1–2 lg/ml. Polyclonal antibodies against nNOS
developed in rabbit or goat were obtained from Cell Signalling
Technology (Danvers, MA, USA) and Novus Biologicals (Littleton,
CO, USA) and used at a dilution of 1:200 and 1:250, respectively.
Anti-dynorphin A antibody developed in rabbit was obtained from
Phoenix Pharmaceuticals Inc. (Burlingame, CA, USA) and used at a
dilution of 1:200. Additional antibodies used against neuronal
markers included antibodies against NeuN developed in guinea
pig and diluted 1:250 (Millipore, Temecula, CA, USA), tryptophan
hydroxylase developed in sheep and diluted 1:500 (Millipore), cal-
citonin gene related peptide developed in goat and diluted 1:2000
(Abcam, Cambridge, MA, USA), and substance P developed in gui-
nea pig and diluted 1:1000 (Novus Biologicals). Various secondary
antibodies used included Cy3-conjugated goat or donkey anti-
mouse and anti-rabbit IgG diluted 1:600, Cy5-conjugated anti-gui-
nea pig IgG diluted 1:600 (Jackson ImmunoResearch Laboratories,
West Grove, PA, USA), AlexaFluor 488-conjugated goat or donkey
anti-rabbit, anti-mouse and anti-guinea pig IgG used at a dilution
of 1:600 (Molecular Probes, Eugene, OR, USA), and AlexaFluor
647-conjugated donkey anti-goat IgG used at a dilution of 1:600
(Jackson ImmunoResearch Laboratories). All primary and second-
ary antibodies were diluted in 50 mM Tris–HCl, pH 7.4, containing
1.5% sodium chloride (TBS), 0.3% Triton X-100 (TBSTr) and 10% nor-
mal goat or normal donkey serum.
Slide mounted sections were removed from storage, air dried
for 10 min, washed for 20 min in TBSTr, and processed for immu-
noﬂuorescence staining, as previously described [23–25]. For dou-
ble or triple immunolabelling, sections were incubated
simultaneously with two or three primary antibodies for 24 h at
4 C. The sections were then washed for 1 h in TBSTr and incubated
with appropriate combinations of secondary antibodies for 1.5 h at
room temperature. Some sections processed for double immunola-
belling were counterstained with Blue Nissl ﬂuorescent Neuro-
Trace (stain N21479) (Molecular Probes, Eugene, OR, USA).
Sections were coverslipped with the antifade medium Fluoro-
mount-G (SouthernBiotech, Birmingham, AB, USA). Control proce-
dures involving omission of one of the primary antibodies with
inclusion of the secondary antibodies used for double labellingindicated absence of inappropriate cross-reactions between pri-
mary and secondary antibodies.
Immunoﬂuorescence was examined on a Zeiss Axioskop2 ﬂuo-
rescence microscope and a Zeiss 710 laser scanning confocal
microscope, using Axiovision 3.0 software or Zeiss ZEN Black
2010 image capture and analysis software (Carl Zeiss Canada, Tor-
onto, Ontario, Canada). Data from wide-ﬁeld and confocal micro-
scopes were collected either as single scan images or z-stack
images with multiple optical scans at z scanning intervals of 0.4–
0.6 lm. Images of immunolabelling obtained with Cy5 ﬂuoro-
chrome were pseudo colored blue. Final images were assembled
using CorelDraw Graphics (Corel Corp., Ottawa, Canada) and Adobe
Photoshop CS software (Adobe Systems, San Jose, CA, USA).
3. Results
3.1. Immunoﬂuorescence of Cx36 in mouse gut
In the CNS, electrical synapses formed by gap junctions contain-
ing Cx36 often, though not always, occur between inhibitory gam-
ma-aminobutyric acid (GABAergic) neurons [18,19]. In view of this,
together with our observations suggesting an impairment of inhib-
itory neuronal control of gut contractility in Cx36 ko mice (de-
scribed below), we examined immunoﬂuorescence labelling of
Cx36 in relation to a broad class of inhibitory enteric neurons, con-
sisting of many if not all that express nNOS in subclasses distin-
guished by their expression of different neuroactive peptides or
other markers [2]. Immunoﬂuorescence labelling for nNOS in gut
was remarkably robust with the antibodies we used, revealing in-
tense labelling for this enzyme in tissues prepared both with the
weak ﬁxation conditions required for immunolabelling of Cx36
and the stronger ﬁxation required for detection of EGFP. Dense
bundles of nNOS-positive ﬁbers were routinely observed in rat
and mouse myenteric plexus, as shown in mouse (Fig. 1A), and
ganglionic clusters of nNOS-positive neuronal cell bodies were also
readily visualized, although their initial and extended dendritic
processes were less evident (Fig. 1B and C). Perhaps relevant, based
on observations below, is that these cell bodies tended to be dis-
tributed in two patterns; either scattered with clear separation be-
tween them (Fig. 1B), or closely clustered with apparent apposition
of their somata (Fig. 1C).
Immunoﬂuorescence labelling of Cx36 was detected in adult
mouse gut, as expected based on a previous report of Cx36 expres-
sion in this tissue [16]. As in all areas of the CNS that we and other
[24–29] have examined, labelling had an exclusively punctate
appearance, which we refer to as Cx36-puncta (Fig. 1D1). Although
not comprehensively examined throughout the intestinal system,
these puncta were observed in duodenum, jejunum and ileum,
but in mouse were most evident in the colon, where they were re-
stricted to the myenteric plexus. In sections of colon double-la-
belled for Cx36 and nNOS, Cx36-puncta were frequently seen in
the vicinity of, and in intimate association with, nNOS-immuno-
positive neurons (Fig. 1D2). Often, Cx36-puncta occurred among
clustered nNOS-positive neurons, and particularly at sites where
these neurons came into close apposition and where multiple
puncta were linearly arranged along the appositions, as shown in
proximal (Fig. 1E) and distal (Fig. 1F) colon. In sections immuno-
stained for both Cx36 and nNOS, and counterstained with ﬂuores-
cence blue Nissl stain, examination of hundreds of nNOS-positive
somata bearing Cx36-puncta revealed only three examples where
these puncta appeared to be lying between a nNOS-positive and
a nNOS-negative somata (Fig. S1). Immunolabelling of Cx36 in
combination with the neuronal marker NeuN also showed associ-
ation of Cx36 with a subpopulation of neuronal somata immunola-
belled for NeuN (not shown).
Fig. 1. Immunoﬂuorescence labelling of nNOS, Cx36, EGFP reporter in EGFP-Cx36 mice and dynorphin A in myenteric plexus of adult mouse colon. (A–C) Labelling of nNOS is
localized to ﬁber bundles (A, arrows) and clusters of neuronal cell bodies (B, arrows and arrowheads) distributed in the myenteric plexus, and the somata of nNOS-positive
cells within these clusters are either scattered (B, arrows) or are closely apposed (B, arrowheads; magniﬁed in C, arrowheads). (D) Punctate appearance of labelling for Cx36 in
the myenteric plexus (D1, arrows), and overlay of the same ﬁeld with labelling for nNOS, showing Cx36-puncta (D2, arrows) distributed among nNOS-positive neurons (D2,
arrowheads). (E–F) Higher magniﬁcations showing Cx36-puncta at appositions between nNOS-positive neuronal somata in proximal (E, arrow) and distal (F, arrow) colon,
and absence of labelling for Cx36 at appositions between nNOS-positive somata (G, arrows) in myenteric plexus of Cx36 ko mice. (H–J) Immunoﬂuorescence labelling of EGFP
in colon, showing EGFP localized to the myenteric plexus in transverse section (H, arrow), and bundles of intensely labelled ﬁbers in horizontal sections (I, arrows; magniﬁed
in J, arrows). (K, L) Images of the same ﬁeld (K1-K3) showing ﬁbers labelled for EGFP (K1, arrows) and nNOS (K2, arrows), with EGFP/nNOS co-distribution seen as yellow in
overlay (K3, arrows), and higher magniﬁcation (L) showing EGFP/nNOS co-localization at nerve terminals and along varicose ﬁbers (arrows). (M) Three images of the same
ﬁeld, showing varicosities along ﬁbers labelled for EGFP (M1, arrows) and dynorphin A (M2, arrows), and EGFP/dynorphin A co-localization seen as yellow (M3, arrows;
magniﬁed in a region of colon in N). Abbreviations in H: MP, myenteric plexus; CM, circular muscle layer; MU mucosal layer; LM, longitudinal muscle layer.
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Cx36-puncta did not occur intracellularly, but rather were distrib-
uted along the periphery of neurons. Scattered nNOS-positive cells
rarely displayed Cx36-puncta. In sections of colon from Cx36 ko
mice, Cx36-puncta were absent among clusters of nNOS-positive
cells, and at appositions between these cells (Fig. 1G). It is of note
that while Cx36-puncta in wild-type mice were routinely encoun-
tered, they were not observed in association with all clustered neu-
rons labelled for nNOS. Although it might therefore be considered
that the single image presented in Fig. 1G is less informative, it is
nevertheless representative of at least a dozen ﬁve by ﬁve mm hor-
izontal sections of gut from Cx36 ko mice in which no Cx36-puncta
were seen in the myenteric plexus. In considering results from
Cx36 ko mice, it is also of note that the intensity of diffuse intracel-
lular ﬂuorescence was not distinguishably different in nNOS-posi-
tive cells of wild-type vs. Cx36 ko mice, indicating absence of
detectable intracellular labelling for Cx36, perhaps due to blockade
of antibody epitope on Cx36 or rapid trafﬁcking of Cx36 to the plas-
ma membrane leaving low cytoplasmic levels.
3.2. EGFP reporter in EGFP-Cx36 mice
In EGFP-Cx36 mice, immunoﬂuorescence labelling for EGFP was
abundant in the duodenum, jejunum and ileum, and was localized
to the myenteric plexus, as shown in a transverse section of the co-
lon (Fig. 1H). In horizontal sections, labelling for EGFP was local-
ized to bundles of ﬁbers (Fig. 1I) as well as at terminals and
along varicosities of these ﬁbers (Fig. 1J). Unfortunately, two fac-
tors precluded analysis of labelling for EGFP in relation to Cx36.
First, neuronal cell bodies, where Cx36 were localized, were never
immunopositive for EGFP, perhaps due to its rapid export from
neuronal cytoplasm or inadequate ﬁxation of EGFP localized in
the cytoplasm of neuronal somata. Second, the strong ﬁxation
(4% formaldehyde) required for detection of EGFP obliterated label-
ling of Cx36, which required weak ﬁxation (1% formaldehyde).
Nevertheless, EGFP reporter expression in the myenteric plexus
of EGFP-Cx36 mice is consistent with Cx36 expression and immu-
noﬂuorescence detection in this plexus.
Given the localization of Cx36 to a subpopulation of nNOS-posi-
tive enteric neurons, we next sought to determine the correspon-
dence of EGFP expression in EGFP-Cx36 mice to that of nNOS in
these mice. In double-labelled horizontal sections of duodenum
(Fig. 1K), labelling for EGFP among ﬁber bundles (Fig. 1K1) is seen
widely co-distributed with those labelled for nNOS (Fig. 1K2).
However, sets of ﬁbers immunopositive for nNOS were clearly de-
void of labelling for EGFP (Fig. 1K3). Detailed inspection revealed
localization of EGFP at nerve terminals and along axonal varicosi-
ties of many but not all nNOS-positive ﬁbers (Fig. 1L), again consis-
tent with Cx36 expression in a subclass of nNOS-containing enteric
neurons. Conversely, only a very few EGFP-positive ﬁbers and ter-
minals lacked labelling for nNOS. Among the repertoire of different
neurotransmitter markers expressed in various subclasses of en-
teric neurons that express nNOS, only one of those in the myenteric
plexus also contain dynorphin A_ENREF_1 (1). Double immunoﬂu-
orescence labelling revealed co-localization of EGFP with some but
not all dynorphin-positive ﬁbers and terminals. Conversely, dynor-
phin was co-localized with some but not all EGFP-positive ﬁbers
and terminals, indicating expression of EGFP reporter for Cx36 in
a subpopulation of nNOS/dynorphin-containing enteric neurons
(Fig. 1M and N). Despite adequate labelling of dynorphin along ter-
minals and ﬁbers under the range of ﬁxation conditions we used,
neuronal somata were not sufﬁciently labelled to allow determina-
tion of Cx36-puncta localization to dynorphin-positive somata.
Expression of EGFP was also examined in relation to enteric
neuronal elements containing tryptophan hydroxylase, calcitonin
gene related peptide and substance P in colonic tissue of EGFP-Cx36 mice. Fibers, nerve terminals and axonal varicosities immu-
nopositive for EGFP lacked overlap with those immunolabelled
for these other neuronal markers (not shown).
3.3. Immunoﬂuorescence of Cx36 in rat gut
Results on relationships between Cx36-puncta and nNOS-con-
taining enteric neurons in rat gut were in general similar to those
found in mouse (Fig. 1). However, Cx36-puncta tended to be more
numerous and were of greater ﬂuorescent intensity than in mouse.
Although sections at short intervals along the entire intestinal
length were not systematically examined, Cx36-puncta were con-
sistently seen in association with nNOS-positive neuronal cell
bodies in the myenteric plexus of randomly selected tissue seg-
ments from the ileum (Fig. 2A and B), jejunum (Fig. 2C and D), duo-
denum (Fig. 2E) and colon (Fig. 2F and G). In samples of gut taken
for counts of Cx36-puncta in each segment of gut (i.e., duodenum,
jejunum, ileum, colon) by wide-ﬁeld microscopy, all of a cumula-
tive total of 1759 puncta counted were associated with, or lying
in close proximity to, a cumulative total of 499 nNOS-positive so-
mata. While this yields an average of 3.5 Cx36-puncta per somata,
through focus microscopy will be required to obtain a more accu-
rate average. As in mouse, Cx36-puncta were distributed around
the periphery of nNOS-containing cells, including at appositions
between these cells (e.g., Fig. 2B, C, F, G). Very rarely, Cx36-puncta
were seen overlying nNOS-positive somata as in some of the
images presented (Fig. 2F and I), but all of these images were z-
stacks of 3–7 lm confocal scans, and through focus analysis indi-
cated those puncta to be localized to neuronal surfaces. Immunola-
belling for nNOS along what appeared to be initial dendritic
segments was only marginally more evident in rat than mouse,
but this nevertheless revealed some Cx36-puncta localized to these
processes (Fig. 2C, H–J), including sites of intersection between
these process (Fig. 2I and J). In cases of sections from rat where
Cx36-puncta were seen in close vicinity but not at the surface of
nNOS-positive somata, high confocal magniﬁcations with in-
creased photomultiplier gain settings invariably revealed associa-
tion of these puncta with nNOS-positive processes (Fig. 2C2,
inset). Immunolabelling of dynorphin A in sections of rat gut was
not of sufﬁcient quality to allow determination of whether Cx36-
puncta were associated with a subclass of nNOS-containing neu-
rons that express dynorphin A.
3.4. Spontaneous mechanical activity
Both excitatory and inhibitory enteric neurons control the activ-
ity of gut smooth muscle, including the rhythmic spontaneous con-
tractile activity that is readily observable in organ bath
preparations in vitro. As we found a close relationship between
Cx36-puncta and nNOS-containing enteric neurons in mouse and
rat gut, we next investigated whether the lack of Cx36 in Cx36
komice was accompanied by alterations in gut smooth muscle mo-
tor behaviour, using colonic smooth muscle strips and focusing
ﬁrst on spontaneous activity. In gut fromWTmice examined under
isometric conditions (Fig. 3A), longitudinal colonic muscle strips
developed spontaneous SMA characterized by the occurrence of
phasic contractions having an amplitude of 1.55 ± 0.35 mN/mm2,
a frequency of 6.5 ± 1.1 cycles/per min and a basal tone of
8.8 ± 0.8 mN/mm2 (Fig. 3A). As shown in Fig. 3B and Table 1, the
amplitude of the spontaneous phasic contractions was signiﬁcantly
increased by 3.1-fold in colonic strips from Cx36 ko mice. As might
be expected from the addition of this large change in amplitude to
the time required to reach maximum contraction and relaxation,
the frequency of contractions was reduced by about 18% in gut
from Cx36 ko vs. WT (Fig. 3, Table 1), but this value failed to reach
signiﬁcance. The basal tone, derived from an average of the inte-
Fig. 2. Immunoﬂuorescence labelling of Cx36 associated with nNOS-positive neurons in sections of the myenteric plexus in various regions of gut from adult rat. (A, B)
Immunolabelling overlay image from ileum, showing Cx36-puncta associated with clusters of nNOS-positive neuronal somata (A, arrows) and at appositions between these
somata, as seen in boxed area in (A) shown magniﬁed in (B, arrow). (C–D) Transverse (C) and horizontal (D) sections of jejunum showing labelling for Cx36 alone (C1, D1,
arrows) and association of Cx36-puncta with nNOS-positive neurons in overlay (C2, D2, arrows). Inset in C2 is a magniﬁcation of the boxed area, with intensiﬁed green
ﬂuorochrome, showing Cx36-puncta association with nNOS-positive processes. (E–G) Overlay images showing Cx36-puncta localized around neurons labelled for nNOS in
duodenum (E, arrows) and colon (F, arrow), with colon shown at higher magniﬁcation in (G, arrows). (H–J) Overlay images showing Cx36 associated with nNOS-positive
processes in duodenum (H, arrows) and colon (I, arrow), and at sites of crossing ﬁbers in colon (J, arrow).
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not different in gut from WT vs. Cx36 ko mice (Fig. 3, Table 1).
Stretching functionality, deﬁned as the length of tissue for a
ﬁxed assigned basal tone and measured after equilibration and
determination of optimal load, was not affected; the average
length of colonic strips from WT mice was 12.6 ± 0.9 mm, whereas
that from Cx36 ko mice was 10.6 ± 0.9 mm). Moreover, tissue-wet
weight (measured immediately after completion of contractility
measurements) and cross-sectional area from both genotypes were
similar (WT and ko, 12.7 ± 0.9 vs. 11.2 ± 0.7 mg; and 0.58 ± 0.04 vs.0.61 ± 0.08 mm2, respectively), thus excluding tissue sample den-
sity as a factor contributing to differences in the contractile prop-
erties of WT vs. Cx36 ko colonic strips.
3.5. Mechanical responses to electrical ﬁeld stimulation
We next investigated how distal colonic longitudinal muscle
strips from WT and Cx36 ko mice respond to parameters of EFS
typically used for eliciting activity in enteric neurons [30]. As
shown by a representative recording of WT colonic responses to
Basal tone 
A wild-type B Cx36 ko 
10 sec 
1 mN 
Fig. 3. Spontaneous SMA in organ bath preparations of colonic muscle strips from adult WT and Cx36 ko mice. (A) Spontaneous SMA is characterized by rhythmic and phasic
contractions in colonic strips from WT mice (A). (B) A signiﬁcant increase in amplitude is seen in strips from Cx36 ko mice. The frequency of the contractions was decreased,
though non-signiﬁcantly in strips from Cx36 ko gut. Dashed line represents similar WT vs. Cx36 ko mean basal tone (expressed as mN) generated by the colonic muscle strips
under isometric conditions and do not reﬂect the integrations of cross-sectional area.
Table 1
Parameters of spontaneous SMA developed by colonic longitudinal smooth muscle
strips from WT and Cx36 ko mice.
Parameters Wild-type Cx36 ko
Amplitude (mN/mm2) 1.55 ± 0.35 4.8 ± 0.67⁄
Basal tone (mN/mm2) 8.8 ± 0.8 9.2 ± 0.9
Frequency (cpm) 6.5 ± 1.1 5.3 ± 1.41
Amplitudes and basal tone are expressed as mN per muscle cross-sectional area
(mm2). Basal tone represents the mean tone generated by colonic strips under
isometric conditions after ﬁnal equilibration and served as a reference for ampli-
tude calculation. Frequency is expressed as contractions per minute (cpm). Asterisk
indicates signiﬁcant difference between WT vs. Cx36 ko. Values are means + and
S.E.M.s, unpaired t-test, ⁄P < 0.05, n = 20.
Basal tone 
A wild-type B Cx36 ko 
10 sec 
R1 
C-off 
EFS 
1 mN 
EFS
10 sec 
1.2 mN 
R1 
Fig. 4. Recordings of colonic mechanical responses to EFS in organ bath preparations of m
biphasic response seen as a ﬁrst relaxation (R1) followed by an off-contraction (C-off) a
biphasic response, but where the relaxation (R1) during the stimulus was signiﬁcantly r
Example from 25% of colonic muscle strips where R1 was replaced by a contraction (C1) f
and do not reﬂect the integrations of cross-sectional area. Dashed lines represent mean
strips from WT vs. Cx36 ko.
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2.9 ± 0.2 mN/mm2) that persisted during the stimulus. A rebound
contraction (off contraction, C-off: 4.62 ± 0.6 mN/mm2) occurred
at the end of the stimulus (Fig. 4A). In colonic strips from Cx36
ko mice, the magnitudes of EFS-induced relaxation were signiﬁ-
cantly decreased by about 50% (Figs. 4B, 5). In 5/20 colonic sam-
ples, this relaxation was replaced by a contraction (C1:
3.84 ± 0.5 mN/mm2) (Fig. 4C). The C-off contraction seen at the
end of the EFS was 1.5-fold signiﬁcantly greater in colonic strips
from Cx36 ko mice compared with those from WT mice (Figs.4A
and B, 5). As in the case of basal tone values observed during mea-
surements of spontaneous muscle activity, there were no differ-
ences in basal tone prior to the onset of the applied EFS to
colonic strips from WT (7.6 ± 0.7 mN/mm2) vs. those from Cx36C Cx36 ko 
C1 
 EFS
10 sec 
1.2 mN 
C-off C-off 
uscle strips from adult WT and Cx36 ko mice. (A) In wild-type mice, EFS induced a
t the end of the applied stimulus. (B) In Cx36-deﬁcient mice, EFS induced a similar
educed and followed at the end of stimulation by a signiﬁcantly increased C-off. (C)
ollowed by a similar increased C-off as seen in all strips. Traces are expressed as mN
basal tone of colonic strips under isometric conditions, which were unchanged in
R1 
C-off 
m
N
 / 
m
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Fig. 5. Summary of EFS-evoked relaxation and contraction of colonic muscle strips
from WT and Cx36 ko mice. Amplitude represents response deviation from basal
tone. The electrically evoked relaxation response (R1) was signiﬁcantly reduced
31%, and C-off contraction was signiﬁcantly increased by 51% in colonic tissues from
Cx36 ko vs. wild-type mice. Values are expressed as mN per muscle cross-sectional
area (mm2) and represent means ± S.E.M.s (unpaired t-test, ⁄P < 0.05, n = 20 samples
per group). Asterisk indicates signiﬁcant difference between WT vs. and Cx36 ko.
EFS parameters were monophasic train with a rate of 0.02 train per second, train
duration of 10 s, pulse rate of 16 pulses per second, pulse duration of 0.5 ms, pulse
delay of zero seconds, and a voltage of 24 V.
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tribution of basal tone levels to the amplitude measurements.
The EFS-induced responses were abolished in the presence of the
Na+ channel blocker tetrodotoxin (TTX, 2 lM), which prevents
neuronal action potential propagation, indicating the neuronal ori-
gin of the EFS response (data not shown).
3.6. Gut responses to carbachol
Colonic muscle strips from WT and Cx36 ko mice were com-
pared for their contractility responsiveness to stimulation by the
broad spectrum (muscarinic and nicotinic) cholinergic receptor
agonist carbachol, which can act on both enteric neurons and gut
smooth muscle [1,31–33]. A one-minute exposure of muscle strips100 µM 
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Fig. 6. Carbachol-induced contraction of colonic muscle strips from WT and Cx36
ko mice. Maximum tension generated by muscle strips in response to carbachol was
calculated as percentage elevation over muscle basal tone before addition of 1, 10
and 100 lM carbachol. Carbachol-induced contraction was signiﬁcantly increased
in colonic strips from Cx36 ko compared to WT mice (asterisks). Value are
expressed as means ± and S.E.M.s, ANOVA followed by post-hoc Tukey-test,
⁄P < 0.05, n = 20.to increasing concentrations of carbachol (1–100 lM) induced con-
tractions in colonic strips from both WT and Cx36 ko mice (Fig. 6).
However, despite lack of an effect to Cx36 ablation on resting basal
tone, carbachol-induced contractile responses in Cx36 ko vs. WT
colonic samples were signiﬁcantly greater by 36.6%, 83.2% and
81.1% at the 1, 10 and 100 lM concentrations of carbachol tested,
respectively, indicating that Cx36 ko mice have altered cellular
physiology in gut at locations of cholinergic agonist sites of action
or at locations downstream of these sites.
4. Discussion
In this report, we present anatomical and physiological evi-
dence implicating a role for interneuronal communication via
gap junctions in the ENS. Our results add a new dimension to the
already complex circuitry and long list of transmitters and neuro-
modulators whereby communication between enteric neurons
governs contractile activity of the intestinal system. Of course, a
great deal remains to be explored concerning enteric neuronal
gap junctions, not the least of which include; (i) electron micro-
scopic identiﬁcation of ultrastructurally-deﬁned, Cx36-containing
gap junctions between enteric neuronal elements; (ii) further char-
acterization of the subclasses of neurons that are linked by gap
junctions; (iii) electrophysiological demonstration that these junc-
tions mediate functional electrical and dye-coupling between en-
teric neurons; (iv) determination of whether contractile activity
in other regions of gut (i.e., duodenum, jejunum, ileum), as well
as contractile activity of circular muscle, display similar deviations
in Cx36 ko mice as observed in longitudinal muscle of colon in
these mice; and (v) elucidation of why electrical coupling between
a subpopulation of enteric neurons is required for their normal
operation in gut enteric circuitry. Some of these points may be con-
sidered in the context of current literature.
4.1. Cx36 localization at gap junctions
In the many CNS structures where Cx36-containing gap junc-
tions between neurons have been found, immunoﬂuorescence
labelling for Cx36 invariably occurs as puncta localized to the sur-
face of neuronal somata and dendrites, or to axon terminals in
cases where these puncta are found at morphologically mixed syn-
apses [23–29]. Little if any Cx36 is detectable in cell cytoplasm,
possibly due to masking of Cx36 antibody epitope or to its rapid
transport to plasma membrane following synthesis. This immu-
nolabelling pattern is perhaps fortuitous because it reveals specif-
ically the cellular locations of Cx36-containing gap junctions,
unmasked by the many other subcellular sites at which Cx36 must
occur during its trafﬁcking to and from these gap junctions. This
conclusion is supported by the strong correlation between the
CNS locations and/or neuron types that display Cx36-puncta and
sites at which ultrastructurally-deﬁned neuronal gap junctions
have been identiﬁed, including those containing Cx36 [17–19,34–
37]. Labelling patterns of Cx36 observed in the CNS also apply to
those in gut, at least under the tissue preparation conditions pres-
ently employed. The disadvantage of this exclusively punctate
immunoﬂuorescence labelling pattern is that it does not always
immediately reveal the cell types to which Cx36-puncta belong,
except in cases where neurons bearing these puncta can be identi-
ﬁed by their morphological features or by simultaneous labelling of
correctly chosen marker proteins. However, as in the CNS, localiza-
tion of Cx36-puncta around the periphery of neuronal somata and
at intersections between neuronal processes in gut almost cer-
tainly reveals sites of gap junction formation at neuronal plasma
membranes. An entirely separate issue not examined in the pres-
ent study is whether one of more of the other connexins expressed
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cells (see Section 1) also participate in neuronal gap junction for-
mation. Resolution of this will likely require comprehensive ultra-
structural immunohistochemical approaches.
4.2. Types of neurons forming gap junctions
It appears that Cx36-containing gap junctions occur between
only a very limited population of enteric neurons. In both mouse
and rat, Cx36-puncta were localized very near or at appositions be-
tween a subpopulation of nNOS-positive neuronal cell bodies with-
in the myenteric plexus. In mice, only a couple of rare examples
among hundreds of nNOS-immunoreactive neuronal somata were
found where these puncta were associated with nNOS-positive
adjacent to nNOS-negative cells. It should be noted that collection
of data from mouse gut was challenging due to the weak ﬁxation
required for immunoﬂuorescence visualization of Cx36; tissue sec-
tions were fragile and occasionally dislodged from slides during
immunohistochemical processing. This was not the case using
the same ﬁxation of rat gut, where labelling of Cx36 was robust
and all or nearly all Cx36-puncta were localized to nNOS-positive
neuronal somata or their albeit weakly labelled processes near
these somata. In rat, it was particularly evident that this associa-
tion occurred in each segment of gut (duodenum, jejunum, ileum,
colon), suggesting that Cx36-containing gap junctions link nNOS-
positive neurons distributed along the entire length of the intesti-
nal system.
The distribution and anatomical features of neurons expressing
nNOS have been well studied in the gut of a variety of species [38–
44], and have been characterized as Dogiel type-I neurons distrib-
uted in the myenteric plexus and rarely in the submucosal plexus
of the small intestine, and in both plexuses of the large intestine
[45]. Regarding the submucosal plexus, the scarcity of nNOS-posi-
tive neurons in this plexus of the small intestine parallels the ab-
sence of Cx36-puncta in this plexus of small intestine, and nNOS-
containing neurons in the submucosal plexus of the large intestine
appear to be devoid of Cx36-puncta. In the myenteric plexus,
nNOS-containing neurons have been functionally characterized
as short- and long-projecting inhibitory circular muscle motor
neurons, descending local reﬂex interneurons and a small percent-
age representing inhibitory longitudinal muscle motor neurons
[2,45]. Our results suggest the presence of Cx36-containing gap
junctions forming electrical synapses between one or more but
not all of the four different classes of enteric neurons that express
nNOS. Alternatively, it may be that subpopulations of neurons
within one or more of these four classes form gap junctions, with
junctions between neurons restricted to coupling those of similar
class (homologous coupling) or coupling those of different classes
(heterologous coupling).
The present data sets do not allow us to distinguish between the
above possibilities. Our results from studies of EGFP-Cx36 mice do,
however, provide some additional clues. Notwithstanding that we
were unable to verify directly whether EGFP expression in these
mice is a reliable reporter for Cx36 expression, the co-localization
of the vast majority of labelling for EGFP with a subset of nNOS-po-
sitive ﬁbers is in accordance with the association of Cx36-puncta
with a subpopulation of nNOS-positive neurons. Lack of overlap
of a minority of EGFP-positive ﬁbers with nNOS suggests either
Cx36 expression in a non-nNOS-containing neuronal population,
false-negative detection of nNOS or false-positive reporter expres-
sion of EFGP. In the myenteric plexus, our results showing co-local-
ization of EGFP with a subset of ﬁbers and terminals containing
dynorphin A suggests Cx36 expression by a subpopulation of
nNOS-positive long-projecting inhibitory circular muscle motor
neurons that selectively express dynorphin A [2]. However, the
dense labelling for EGFP we found in myenteric plexus and sparselabelling in the muscle layers of gut would be more consistent with
EGFP expression in descending local reﬂex interneurons, which
contain nNOS and innervate enteric ganglia [2]. In attempts to rec-
oncile all of the above possibilities, it may simply be considered
that just as neurotransmitter markers distinguish anatomically
and functionally characterized enteric neuronal populations, so
to Cx36 expression and electrical synapse formation distinguishes
an as yet poorly understood population of enteric neurons that
contains its own distinct set of transmitter and neuromodulator
markers.
4.3. Spontaneous gut contractility after Cx36 ablation
This report is the ﬁrst to demonstrate an abnormal phenotype
in contractile activity of gut after Cx36 ablation. Our organ bath
studies revealed that loss of Cx36 caused an increase in the ampli-
tude of colonic spontaneous smooth muscle contractions, reduced
or abolished EFS-induced relaxation and increased the contractile
response after cessation of EFS. The patterns of activity of normal
murine colon we observed in organ bath preparations were typical
of those generally reported [30] and may be considered in the con-
text of current views of how the ENS integrates sensory informa-
tion from multiple locations and ultimately generates
appropriate motility responses. Spontaneous myogenic contractile
activity of murine colonic circular and longitudinal muscle is char-
acterized by rhythmic and phasic contractions originating in
peacemaker cells (i.e., interstitial cells of Cajal) intercalated among
enteric neurons and gut smooth muscle cells [13] which is under
tonic neural inﬂuence [46]. Final effector excitatory motor neurons
that release acetylcholine (ACh) and tachykinins are mainly impli-
cated in increasing the pressure waves and exert a tonic excitatory
effect on basal tone [47]. Relaxation of the gastrointestinal smooth
muscle, which is a feature of several physiologic digestive reﬂexes,
originates from spontaneously active inhibitory motor neurons
that maintain gut smooth musculature under tonic inhibition. This
process appears to occur largely by mechanisms involving release
of non-adrenergic non-cholinergic (NANC) (e.g., NO) transmitters
from enteric nerves, as suggested by increased muscle contractility
observed in the presence of nNOS inhibitor NG-nitro-l-arginine
methyl ester (L-NAME) or TTX, supporting the role of enteric neu-
rons and neuronal NO [46]. Thus, NO produced by nNOS in nitrer-
gic neurons in the ENS is viewed as a neurotransmitter that acts on
NO-sensitive guanylyl cyclase in its effector cells, thereby decreas-
ing the tone of various types of smooth muscle, including colonic
musculature [48]. More speciﬁcally, there is evidence for a major
role of NO as a NANC neurotransmitters in longitudinal muscle of
mouse distal colon [49]. As basal tone was unaffected in colon from
Cx36 ko mice, our results on spontaneous contractile properties of
gut musculature from these mice may be considered in relation to
concepts surrounding the role of nitrergic neurons in regulating
gut motility. We suggest that the increased amplitude of spontane-
ous contractions in the absence of Cx36 reﬂects compromised
activity of nitrergic inhibitory neurons, a possibility consistent
with the localization of Cx36-puncta to nNOS-containing enteric
neurons in normal mice.
4.4. Electrically-induced gut contractility after Cx36 ablation
Colonic muscle strips from normal mice produced a biphasic re-
sponse to EFS, consisting of an inhibitory relaxation (R1) compo-
nent and an excitatory contractile (C-off) component upon
termination of EFS. Both of these components were abrogated in
the presence of TTX, demonstrating a neuronal origin of the re-
sponses. Current evidence in rodents suggests that inhibitory
NANC neurotransmitters are released during enteric nerve stimu-
lation. We and others have demonstrated that the relaxation re-
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cantly blocked by L-NAME, suggesting that NO contributes to the
mediation of this relaxation [46,50,51]. This is consistent with
the absence of EFS-induced relaxation in nNOS-deﬁcient mice
[52]. The C-off results mainly from acetylcholine release from
excitatory motor neurons, because it is decreased in the presence
of atropine [50]. The C-off excitatory response also appears to be
subject to regulation by NO, as suggested by ﬁndings that the
amplitude of the C-off contraction is signiﬁcantly increased in
the presence of L-NAME [46]. Based on the foregoing and as in
the case of spontaneous SMA, we may infer that NANC enteric neu-
rons, speciﬁcally nitrergic neurons, in Cx36 ko mice have reduced
inhibitory capacity to elicit smooth muscle relaxation following
their excitation by EFS.
4.5. Altered responses of Cx36 ko gut to carbachol
The increased contractile responsiveness of colonic muscle
strips from Cx36 ko vs.WTmice to cholinergic receptor stimulation
with carbachol is more difﬁcult to align with our favoured scenario
of functionally compromised nitrergic enteric neurons in these
mice. For example, carbachol can act directly on smooth muscle,
raising the possibility of altered smooth muscle sensitivity to cho-
linergic stimulation. However, it is also possible that cholinergic
transmission contributes to activation of nitrergic neurons [53].
In this event, a reduced capacity for cholinergic activation of these
neurons, or any other means of their activation for that matter,
arising from a loss of Cx36 could result in partial withdrawal of
their tonic inhibitory control of smooth muscle, which could be
manifest as exaggerated responsiveness of smooth muscle to direct
muscle stimulation, in this case with carbachol. Distinguishing be-
tween these possibilities will be aided by pharmacological dissec-
tion of the basis for the altered cholinergic responsiveness.
4.6. Basis for compromised nitrergic neuronal activity after Cx36
ablation
Assuming further work supports the existence of gap junctional
coupling between nitrergic neurons in the rodent intestinal sys-
tem, how could the loss of Cx36 expression in a subpopulation of
these neurons account for what we postulate results in their re-
duced activity and EFS responsiveness? As noted in the Introduc-
tion, neuronal gap junctions forming electrical synapses between
neurons in the CNS enable synchronization of subthreshold mem-
brane oscillations within networks of gap junctionally coupled
neurons [17–19]. It is thought that excitatory inputs subthreshold
for neuronal activation are distributed via neuronal gap junctions
in such networks, bringing coupled neurons collectively closer to
threshold for ﬁring, and ultimately resulting in their recruitment
into ensembles of neurons with synchronized ﬁring. Electrical syn-
apses similarly distribute inhibitory input and hyperpolarization
within gap junctionally coupled networks [54,55]. Gene deletion
of Cx36 in mice is accompanied by functional deﬁcits in neuronal
network properties [18,19]. In Cx36 ko mice, we found a profound
reduction in capacity to evoke presynaptic inhibition of primary
afferent ﬁbers, and proposed that this may be due to a deﬁciency
of gap junctions coupling between spinal cord interneurons that
mediate this inhibition [23]. Similarly, it is conceivable that syn-
chronized concerted activity afforded by electrical synapses be-
tween a distinct set of nNOS-containing enteric neurons is
required for their maximal tonic or electrically evoked inhibitory
inﬂuence on gut smooth muscle contractility. If the level of activity
of these cells is correlated with levels of their NO production [56],
then all cell types that are targets of NO release from this set of
coupled nNOS-containing cells may be affected by their reducedactivity in Cx36 ko mice, including smooth muscle cells and other
neurons, as well as perhaps interstitial cells of Cajal. Actions on the
latter cells could impact on their pacemaker activities. A further le-
vel of complexity may be envisioned based on observations that
gap junctionally coupled inhibitory interneurons in some brain
structures such as the cerebellar cortex [57] include those that ex-
press nNOS [56], and that NO is among the many transmitters
capable of regulating gap junctional coupling between central neu-
rons [58,59]. If similar NO-mediated modulation of neuronal gap
junctional coupling is extant in the gut, then the activity of the
set of coupled nNOS-containing neurons may be subject to feed-
back regulation through an effect of NO on their junctional
coupling.
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